Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30785063 | 0.80 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL6784765 | 0.80 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL6535599 | 0.79 | NFE2L2 (0.45) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7521503 | 0.79 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11306042 | 0.79 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7509528 | 0.79 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7509892 | 0.79 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL28392341 | 0.79 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL630768 | 0.75 | CA1 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27509890 | 0.74 | APP (0.44) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210078956-A1 | PROCESS FOR PREPARING ELAGOLIX SODIUM AND INTERMEDIATES THEREOF | SCINOPHARM TAIWAN, LTD. (TW) | 2021-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210078956-A1 | PROCESS FOR PREPARING ELAGOLIX SODIUM AND INTERMEDIATES THEREOF | OGG1, ELP1, UNG | CA1 3496/4885CA2 3055/4885CA12 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.